Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Pharmacometabolomics Informs About Pharmacokinetic Profile of Methylphenidate

Research output: Contribution to journalJournal articleResearchpeer-review

DOI

  1. Model-Based Prediction of Plasma Concentration and Enterohepatic Circulation of Total Bile Acids in Humans

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Mechanism-Based Modeling of Gastric Emptying Rate and Gallbladder Emptying in Response to Caloric Intake

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Interventional cohort study of prolonged use (>72 hours) of paracetamol in neonates: protocol of the PARASHUTE study

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Obesity-induced CYP2E1 activity in children

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Sparsom evidens for effekt og sikkerhed af propranolol ved eksamensangst

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Ventrikelaspiration er meget sjældent indiceret ved forgiftninger

    Research output: Contribution to journalJournal articleResearchpeer-review

  • INDICES consortium
View graph of relations

Carboxylesterase 1 (CES1) metabolizes methylphenidate and other drugs. CES1 gene variation only partially explains pharmacokinetic (PK) variability. Biomarkers predicting the PKs of drugs metabolized by CES1 are needed. We identified lipids in plasma from 44 healthy subjects that correlated with CES1 activity as determined by PK parameters of methylphenidate including a ceramide (q value = 0.001) and a phosphatidylcholine (q value = 0.005). Carriers of the CES1 143E allele had decreased methylphenidate metabolism and altered concentration of this phosphatidylcholine (q value = 0.040) and several high polyunsaturated fatty acid lipids (PUFAs). The half-maximal inhibitory concentration (IC50 ) values of chenodeoxycholate and taurocholate were 13.55 and 19.51 μM, respectively, consistent with a physiological significance. In silico analysis suggested that bile acid inhibition of CES1 involved both binding to the active and superficial sites of the enzyme. We initiated identification of metabolites predicting PKs of drugs metabolized by CES1 and suggest lipids to regulate or be regulated by this enzyme.

Original languageEnglish
JournalCPT: pharmacometrics & systems pharmacology
Volume7
Issue number8
Pages (from-to)525-533
Number of pages9
ISSN2163-8306
DOIs
Publication statusPublished - Aug 2018

ID: 55270223